Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

Clinical trial NCT00004163 · COMPLETED

Trial details

NCT number: NCT00004163
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 1999-10-01
Primary completion: 2001-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.